# Consensus Cloud Solutions, Inc.: financial statements, quarterly

CCSI · Nasdaq · CIK 1866633 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ccsi.md) · [Financials](/companies/ccsi/financials.md) · [Filings](/companies/ccsi/filings.md) · [Insiders](/companies/ccsi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ccsi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [90.6](/filings/0001866633-24-000033.md) | [87.8 d](/filings/0001866633-26-000004.md) | [88.1](/filings/0001866633-25-000010.md) | [87.5](/filings/0001866633-25-000019.md) | [87.8](/filings/0001866633-25-000025.md) | [87.0 d](/filings/0001866633-26-000004.md) | [87.1](/filings/0001866633-26-000011.md) | [87.7](/filings/0001866633-26-000017.md) | [87.8](/filings/0001866633-25-000025.md) | [87.1 d](/filings/0001866633-26-000004.md) | [88.5](/filings/0001866633-26-000011.md) | [91.4](/filings/0001866633-26-000017.md) |
| Cost of revenue | $m | [16.9](/filings/0001866633-24-000033.md) | [16.7 d](/filings/0001866633-26-000004.md) | [17.0](/filings/0001866633-25-000010.md) | [17.1](/filings/0001866633-25-000019.md) | [17.7](/filings/0001866633-25-000025.md) | [17.9 d](/filings/0001866633-26-000004.md) | [18.1](/filings/0001866633-26-000011.md) | [17.6](/filings/0001866633-26-000017.md) | [17.5](/filings/0001866633-25-000025.md) | [17.4 d](/filings/0001866633-26-000004.md) | [16.9](/filings/0001866633-26-000011.md) | [18.3](/filings/0001866633-26-000017.md) |
| Gross profit | $m | [73.7](/filings/0001866633-24-000033.md) | [71.0 d](/filings/0001866633-26-000004.md) | [71.1](/filings/0001866633-25-000010.md) | [70.4](/filings/0001866633-25-000019.md) | [70.1](/filings/0001866633-25-000025.md) | [69.1 d](/filings/0001866633-26-000004.md) | [69.1](/filings/0001866633-26-000011.md) | [70.1](/filings/0001866633-26-000017.md) | [70.2](/filings/0001866633-25-000025.md) | [69.7 d](/filings/0001866633-26-000004.md) | [71.6](/filings/0001866633-26-000011.md) | [73.1](/filings/0001866633-26-000017.md) |
| Research and development | $m | [1.7](/filings/0001866633-24-000033.md) | [2.4 d](/filings/0001866633-26-000004.md) | [1.9](/filings/0001866633-25-000010.md) | [1.6](/filings/0001866633-25-000019.md) | [2.0](/filings/0001866633-25-000025.md) | [2.1 d](/filings/0001866633-26-000004.md) | [1.7](/filings/0001866633-26-000011.md) | [1.7](/filings/0001866633-26-000017.md) | [2.0](/filings/0001866633-25-000025.md) | [2.1 d](/filings/0001866633-26-000004.md) | [1.9](/filings/0001866633-26-000011.md) | [2.4](/filings/0001866633-26-000017.md) |
| Operating income | $m | [38.9](/filings/0001866633-24-000033.md) | [35.5 d](/filings/0001866633-26-000004.md) | [37.7](/filings/0001866633-25-000010.md) | [39.9](/filings/0001866633-25-000019.md) | [38.4](/filings/0001866633-25-000025.md) | [33.4 d](/filings/0001866633-26-000004.md) | [37.5](/filings/0001866633-26-000011.md) | [39.0](/filings/0001866633-26-000017.md) | [37.9](/filings/0001866633-25-000025.md) | [35.8 d](/filings/0001866633-26-000004.md) | [37.7](/filings/0001866633-26-000011.md) | [36.8](/filings/0001866633-26-000017.md) |
| Interest expense | $m | [12.6](/filings/0001866633-23-000040.md) | [7.4 d](/filings/0001866633-24-000004.md) | [6.2](/filings/0001866633-24-000009.md) | [8.7](/filings/0001866633-24-000021.md) | [9.8](/filings/0001866633-25-000025.md) | [9.4 d](/filings/0001866633-26-000004.md) | [9.0](/filings/0001866633-26-000011.md) | [8.7](/filings/0001866633-26-000017.md) | [8.8](/filings/0001866633-25-000025.md) | [9.0 d](/filings/0001866633-26-000004.md) | [7.8](/filings/0001866633-26-000011.md) | [7.9](/filings/0001866633-26-000017.md) |
| Income tax | $m | [7.5](/filings/0001866633-24-000033.md) | [7.0 d](/filings/0001866633-26-000004.md) | [9.9](/filings/0001866633-25-000010.md) | [8.6](/filings/0001866633-25-000019.md) | [6.1](/filings/0001866633-25-000025.md) | [8.1 d](/filings/0001866633-26-000004.md) | [6.7](/filings/0001866633-26-000011.md) | [7.8](/filings/0001866633-26-000017.md) | [7.9](/filings/0001866633-25-000025.md) | [7.1 d](/filings/0001866633-26-000004.md) | [7.4](/filings/0001866633-26-000011.md) | [8.3](/filings/0001866633-26-000017.md) |
| Net income | $m | [24.0](/filings/0001866633-24-000033.md) | [16.8 d](/filings/0001866633-26-000004.md) | [26.4](/filings/0001866633-25-000010.md) | [23.9](/filings/0001866633-25-000019.md) | [21.1](/filings/0001866633-25-000025.md) | [18.1 d](/filings/0001866633-26-000004.md) | [21.2](/filings/0001866633-26-000011.md) | [20.8](/filings/0001866633-26-000017.md) | [22.1](/filings/0001866633-25-000025.md) | [20.5 d](/filings/0001866633-26-000004.md) | [24.7](/filings/0001866633-26-000011.md) | [27.4](/filings/0001866633-26-000017.md) |
| Diluted EPS | $ per share | [1.22](/filings/0001866633-24-000033.md) | not reported | [1.37](/filings/0001866633-25-000010.md) | [1.24](/filings/0001866633-25-000019.md) | [1.09](/filings/0001866633-25-000025.md) | not reported | [1.07](/filings/0001866633-26-000011.md) | [1.07](/filings/0001866633-26-000017.md) | [1.15](/filings/0001866633-25-000025.md) | not reported | [1.30](/filings/0001866633-26-000011.md) | [1.43](/filings/0001866633-26-000017.md) |
| Basic EPS | $ per share | [1.22](/filings/0001866633-24-000033.md) | not reported | [1.37](/filings/0001866633-25-000010.md) | [1.24](/filings/0001866633-25-000019.md) | [1.09](/filings/0001866633-25-000025.md) | not reported | [1.08](/filings/0001866633-26-000011.md) | [1.07](/filings/0001866633-26-000017.md) | [1.16](/filings/0001866633-25-000025.md) | not reported | [1.32](/filings/0001866633-26-000011.md) | [1.49](/filings/0001866633-26-000017.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [156](/filings/0001866633-23-000040.md) | [88.7](/filings/0001866633-25-000004.md) | [61.5](/filings/0001866633-24-000009.md) | [49.2](/filings/0001866633-24-000021.md) | [54.6](/filings/0001866633-24-000033.md) | [33.5](/filings/0001866633-26-000004.md) | [53.4](/filings/0001866633-25-000010.md) | [57.9](/filings/0001866633-25-000019.md) | [97.6](/filings/0001866633-25-000025.md) | [74.7](/filings/0001866633-26-000017.md) | [92.3](/filings/0001866633-26-000011.md) | [98.9](/filings/0001866633-26-000017.md) |
| Current assets | $m | [193](/filings/0001866633-23-000040.md) | [125](/filings/0001866633-25-000004.md) | [98.7](/filings/0001866633-24-000009.md) | [84.0](/filings/0001866633-24-000021.md) | [89.8](/filings/0001866633-24-000033.md) | [74.5](/filings/0001866633-26-000004.md) | [91.5](/filings/0001866633-25-000010.md) | [92.4](/filings/0001866633-25-000019.md) | [128](/filings/0001866633-25-000025.md) | [117](/filings/0001866633-26-000017.md) | [130](/filings/0001866633-26-000011.md) | [134](/filings/0001866633-26-000017.md) |
| Total assets | $m | [707](/filings/0001866633-23-000040.md) | [647](/filings/0001866633-25-000004.md) | [621](/filings/0001866633-24-000009.md) | [608](/filings/0001866633-24-000021.md) | [622](/filings/0001866633-24-000033.md) | [602](/filings/0001866633-26-000004.md) | [630](/filings/0001866633-25-000010.md) | [642](/filings/0001866633-25-000019.md) | [675](/filings/0001866633-25-000025.md) | [664](/filings/0001866633-26-000017.md) | [679](/filings/0001866633-26-000011.md) | [697](/filings/0001866633-26-000017.md) |
| Current liabilities | $m | [85.1](/filings/0001866633-23-000040.md) | [71.4](/filings/0001866633-25-000004.md) | [74.2](/filings/0001866633-24-000009.md) | [80.4](/filings/0001866633-24-000021.md) | [85.3](/filings/0001866633-24-000033.md) | [79.3](/filings/0001866633-26-000004.md) | [73.3](/filings/0001866633-25-000010.md) | [61.9](/filings/0001866633-25-000019.md) | [69.7](/filings/0001866633-25-000025.md) | [65.5](/filings/0001866633-26-000017.md) | [72.2](/filings/0001866633-26-000011.md) | [70.6](/filings/0001866633-26-000017.md) |
| Total liabilities | $m | [906](/filings/0001866633-23-000040.md) | [823](/filings/0001866633-25-000004.md) | [773](/filings/0001866633-24-000009.md) | [733](/filings/0001866633-24-000021.md) | [716](/filings/0001866633-24-000033.md) | [682](/filings/0001866633-26-000004.md) | [679](/filings/0001866633-25-000010.md) | [668](/filings/0001866633-25-000019.md) | [678](/filings/0001866633-25-000025.md) | [650](/filings/0001866633-26-000017.md) | [657](/filings/0001866633-26-000011.md) | [655](/filings/0001866633-26-000017.md) |
| Long-term debt | $m | [795](/filings/0001866633-23-000040.md) | [725](/filings/0001866633-25-000004.md) | [672](/filings/0001866633-24-000009.md) | [626](/filings/0001866633-24-000021.md) | [603](/filings/0001866633-24-000033.md) | [574](/filings/0001866633-26-000004.md) | [578](/filings/0001866633-25-000010.md) | [578](/filings/0001866633-25-000019.md) | [579](/filings/0001866633-25-000025.md) | [551](/filings/0001866633-26-000017.md) | [550](/filings/0001866633-26-000011.md) | [548](/filings/0001866633-26-000017.md) |
| Current portion of debt | $m | not reported | [8.6](/filings/0001866633-25-000004.md) | [0.0](/filings/0001866633-24-000009.md) | [16.6](/filings/0001866633-24-000021.md) | [9.4](/filings/0001866633-24-000033.md) | [18.9](/filings/0001866633-26-000004.md) | [6.1](/filings/0001866633-25-000010.md) | [0.0](/filings/0001866633-25-000019.md) | [0.0](/filings/0001866633-25-000025.md) | [7.0](/filings/0001866633-26-000017.md) | [7.0](/filings/0001866633-26-000011.md) | [7.0](/filings/0001866633-26-000017.md) |
| Shareholders' equity | $m | [(199)](/filings/0001866633-24-000033.md) | [(176)](/filings/0001866633-26-000004.md) | [(152)](/filings/0001866633-25-000019.md) | [(124)](/filings/0001866633-25-000025.md) | [(93.2)](/filings/0001866633-25-000025.md) | [(79.5)](/filings/0001866633-26-000017.md) | [(49.4)](/filings/0001866633-26-000017.md) | [(26.5)](/filings/0001866633-26-000017.md) | [(2.6)](/filings/0001866633-25-000025.md) | [13.8](/filings/0001866633-26-000017.md) | [22.0](/filings/0001866633-26-000017.md) | [41.6](/filings/0001866633-26-000017.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [60.0 d](/filings/0001866633-24-000033.md) | [2.0 d](/filings/0001866633-26-000004.md) | [44.7](/filings/0001866633-25-000010.md) | [24.4 d](/filings/0001866633-25-000019.md) | [41.6 d](/filings/0001866633-25-000025.md) | [11.1 d](/filings/0001866633-26-000004.md) | [40.9](/filings/0001866633-26-000011.md) | [28.3 d](/filings/0001866633-26-000017.md) | [51.6 d](/filings/0001866633-25-000025.md) | [15.2 d](/filings/0001866633-26-000004.md) | [45.8](/filings/0001866633-26-000011.md) | [33.3 d](/filings/0001866633-26-000017.md) |
| Capital expenditure | $m | [10.1 d](/filings/0001866633-24-000033.md) | [7.7 d](/filings/0001866633-26-000004.md) | [8.9](/filings/0001866633-25-000010.md) | [8.6 d](/filings/0001866633-25-000019.md) | [8.0 d](/filings/0001866633-25-000025.md) | [8.0 d](/filings/0001866633-26-000004.md) | [7.2](/filings/0001866633-26-000011.md) | [8.0 d](/filings/0001866633-26-000017.md) | [7.2 d](/filings/0001866633-25-000025.md) | [7.9 d](/filings/0001866633-26-000004.md) | [7.4](/filings/0001866633-26-000011.md) | [7.8 d](/filings/0001866633-26-000017.md) |
| Share repurchases | $m | [3.8](/filings/0001866633-24-000033.md) | [8.6 d](/filings/0001866633-25-000004.md) | [0.7](/filings/0001866633-25-000010.md) | [0.0 d](/filings/0001866633-25-000019.md) | [0.0 d](/filings/0001866633-25-000025.md) | [0.3 d](/filings/0001866633-26-000004.md) | not reported | [12.5](/filings/0001866633-26-000017.md) | [2.6](/filings/0001866633-25-000025.md) | [8.0 d](/filings/0001866633-26-000004.md) | [17.2](/filings/0001866633-26-000011.md) | [9.7](/filings/0001866633-26-000017.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.9](/filings/0001866633-23-000040.md) | [19.9](/filings/0001866633-24-000009.md) | [19.7](/filings/0001866633-24-000021.md) | [19.6](/filings/0001866633-24-000033.md) | [19.2](/filings/0001866633-25-000010.md) | [19.3](/filings/0001866633-25-000019.md) | [19.4](/filings/0001866633-25-000025.md) | [19.7](/filings/0001866633-26-000011.md) | [19.5](/filings/0001866633-26-000017.md) | [19.3](/filings/0001866633-25-000025.md) | [19.0](/filings/0001866633-26-000011.md) | [19.2](/filings/0001866633-26-000017.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,324,922 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001866633-26-000017.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.